| Overview |
| bsm-90231r-50µL |
| ELP4 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human ELP4 |
| 313-364/424 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 26610 |
| Q96EB1 |
| ELP4; Elongator Acetyltransferase Complex Subunit 4; PAXNEB; Elongator Complex Protein 4; PAX6 Neighbor Gene Protein; C11orf19; HELP4; Elongation Protein 4 Homolog (S. Cerevisiae); Chromosome 11 Open Reading Frame 19; Elongation Protein 4 Homolog; DJ68P15A.1; C11ORF19; PAX6NEB; AN2; AN |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |